ESC 365 - Primary prevention of sudden cardiac death in hypertrophic cardiomyopathy: are we in line with the guidelines?

ESC Premium Access

Primary prevention of sudden cardiac death in hypertrophic cardiomyopathy: are we in line with the guidelines?

Session: Prevention of sudden cardiac death in hypertrophic cardiomyopathy

Topic: Cardiomyopathies

Speaker: Doctor M. Mirabel (Paris, FR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Mariana Mirabel

Montsouris Mutualist Institute, Paris (France)

5 presentations

3 followers

4 more presentations in this session

State of the Art: sudden cardiac death prevention in hypertrophic cardiomyopathy

Speaker: Doctor A. Anastasakis (Athens, GR)

Left atrial diameter predicted from left atrial volume in the risk assessment of sudden cardiac death in hypertrophic cardiomyopathy - potential clinical consequence for the individual patient

Speaker: Miss H. Mills (Copenhagen, DK)

Predictive value of classic sudden death risk factors in pediatric-onset hypertrophic cardiomyopathy

Speaker: Mr N. Maurizi (Lausanne, CH)

Prevention of sudden death after septal reduction therapy

Speaker: Professor H. Seggewiss (Wurzburg, DE)

Access the full session

Prevention of sudden cardiac death in hypertrophic cardiomyopathy

Speakers: Doctor M. Mirabel, Doctor A. Anastasakis, Miss H. Mills, Mr N. Maurizi, Professor H. Seggewiss

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources